Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.

@article{Diehl2007EarlyIA,
  title={Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.},
  author={V. Diehl and M. Fuchs},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2007},
  volume={18 Suppl 9},
  pages={
          ix71-9
        }
}
  • V. Diehl, M. Fuchs
  • Published 2007
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment strategies of early stage Hodgkin lymphoma (HL) have changed during recent years. Until recently, extended field (EF) irradiation has been considered the standard treatment. However, due to the recognition of the high relapse rate and the fatal long-term effects, EF radiotherapy (radiation to initially involved and adjacent lymph node areas) is now being abandoned by most study groups. Instead, for favourable early stage disease, short duration chemotherapy for control of occult… CONTINUE READING
    19 Citations
    Hodgkin lymphoma in Tyrol—a population-based study
    • 7
    • PDF
    Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy.
    • 7
    Hodgkin’s Lymphoma
    • 7
    Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
    • 80
    Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma
    • 15
    • Highly Influenced

    References

    SHOWING 1-10 OF 19 REFERENCES
    Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    • 260
    • Highly Influential
    • PDF
    Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.
    • 308
    Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
    • 61
    Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
    • 73
    Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    • 726
    • PDF
    Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
    • O. Press, M. Leblanc, +7 authors R. Fisher
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2001
    • 136
    Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.
    • 73
    ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
    • 77